Analysis of the drug treatment groups revealed lower levels of serum total IgE, OVA-specific IgE, and Th2 cytokines, including IL-4, IL-5, IL-13, IFN-γ, and eosinophils, compared to the allergy group. This evidence concerns the gene IL13 and allergic disease.